FDA Panel Recommends No Warning for Low-Dose Emsam

Drug Industry Daily
KEYWORDS FDA
A A

A low-dose version of Somerset Pharmaceuticals’ experimental Emsam antidepressant patch can be safely administered without dietary restrictions, according to an FDA advisory panel.

To View This Article:

Login

Subscribe To Drug Industry Daily